日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Soluble Markers of Immune Activation Differentially Normalize and Selectively Associate with Improvement in AST, ALT, Albumin, and Transient Elastography During IFN-Free HCV Therapy.

在无干扰素 HCV 治疗期间,免疫激活的可溶性标志物可差异性地正常化,并选择性地与 AST、ALT、白蛋白和瞬时弹性成像的改善相关

Kostadinova Lenche, Shive Carey L, Zebrowski Elizabeth, Fuller Brianna, Rife Kelsey, Hirsch Amy, Compan Anita, Moreland Anita, Falck-Ytter Yngve, Popkin Daniel L, Anthony Donald D

Clinical Pharmacy. 2nd ed

临床药学(第2版)

Davitkov, Perica; Chandar, Apoorva Krishna; Hirsch, Amy; Compan, Anita; Silveira, Marina G; Anthony, Donald D; Smith, Suzanne; Gideon, Clare; Bonomo, Robert A; Falck-Ytter, Yngve; Guidone, Daniel